Uams Medical Center | |
4301 West Markham Street Mail Slot 612, Little Rock, Arkansas 72205 | |
(501) 686-5000 | |
Name | Uams Medical Center |
---|---|
Type | Acute Care Hospital |
Location | 4301 West Markham Street Mail Slot 612, Little Rock, Arkansas |
Ownership | Government - State |
Emergency Services | Yes |
Medicare ID (CCN) | 040016 |
NPI Number | 1568708170 |
Organization Name | UAMS MEDICAL CENTER |
Address | 4601 W Markham St, Apt 4032 Uams Residence Hall, Little Rock, AR 72205 |
Hospital Type | General Acute Care Hospital |
Phone Number | 347-475-7014 |
News Archive
Oncolytics Biotech Inc. today announced updated results from a Phase I/II U.K. trial (REO 011) of REOLYSIN(R) combined with paclitaxel/carboplatin for patients with advanced cancers in a poster presentation at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference being held in Boston, Massachusetts.
Patients with hepatocellular carcinoma (HCC) waiting for a liver transplant in the USA are now significantly less likely to receive a new liver than they were around a decade ago. A nationwide study presented today at The International Liver Congress™ 2018 in Paris, France, has confirmed that patients with HCC on the liver transplant list in the USA were more than 50% less likely to receive a transplant in 2014-2016 than they were in 2005-2007.
Combination drug therapy effectively reduces 90 percent of HIV deaths in African-American injection drug users when they are given ample access to care, according to a new Academy study in the June issue of the American Journal of Epidemiology.
Workers experiencing job and financial insecurity are less likely to follow the CDC's guidelines for COVID-19, such as physical distancing, limiting trips from home and washing hands, according to a Washington State University study.
› Verified 1 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Oncolytics Biotech Inc. today announced updated results from a Phase I/II U.K. trial (REO 011) of REOLYSIN(R) combined with paclitaxel/carboplatin for patients with advanced cancers in a poster presentation at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference being held in Boston, Massachusetts.
Patients with hepatocellular carcinoma (HCC) waiting for a liver transplant in the USA are now significantly less likely to receive a new liver than they were around a decade ago. A nationwide study presented today at The International Liver Congress™ 2018 in Paris, France, has confirmed that patients with HCC on the liver transplant list in the USA were more than 50% less likely to receive a transplant in 2014-2016 than they were in 2005-2007.
Combination drug therapy effectively reduces 90 percent of HIV deaths in African-American injection drug users when they are given ample access to care, according to a new Academy study in the June issue of the American Journal of Epidemiology.
Workers experiencing job and financial insecurity are less likely to follow the CDC's guidelines for COVID-19, such as physical distancing, limiting trips from home and washing hands, according to a Washington State University study.
› Verified 1 days ago
Chi-st Vincent Infirmary Acute Care Hospital Location: Two St Vincent Circle, Little Rock, Arkansas 72205 Phone: (501) 552-3000 | |
Uams Medical Center Acute Care Hospital Location: 4301 West Markham Street Mail Slot 612, Little Rock, Arkansas 72205 Phone: (501) 686-5000 | |
Baptist Health Medical Center-little Rock Acute Care Hospital Location: 9601 Interstate, Little Rock, Arkansas 72205 Phone: (501) 202-2000 | |
Arkansas Heart Hospital, Llc Acute Care Hospital Location: 1701 S Shackleford Road, Little Rock, Arkansas 72211 Phone: (501) 219-7000 | |
Arkansas Childrens Hospital Childrens Hospital Location: 1 Children's Way, Slot 301, Little Rock, Arkansas 72202 Phone: (501) 364-1100 | |
Arkansas State Hospital Psychiatric Hospital Location: 305 S Palm Street, Little Rock, Arkansas 72205 Phone: (501) 686-9000 |